Diligence memo · auto-generated · as of July 2, 2026
Global Lyme Diagnostics, LLC
Global Lyme Diagnostics, LLC looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Global Lyme Diagnostics, LLC operates in Biotechnology, based in RESEARCH TRIANGLE PARK.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Global Lyme Diagnostics, LLC has raised $750K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $600K on 2017-02-13.
Most recent recorded round closed around 2017-02-13.
Valuation (modeled)modeled
Provath models Global Lyme Diagnostics, LLC at approximately $33M (range $320K–$376M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.57× the median modeled value of Pre-Seed Biotechnology companies in 2016–2018 (152 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 23 months.
Last raise 9.4 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 4.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 15% of Biotechnology peers (4293 compared).
Modeled value ranks above 37% of those peers.
Closest niche peers: New Vital Signs, Inc., Cerebral Magnetics INC, NutriBand Inc., Jivana Biotechnology Inc, AnTolRx, Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.